A Single-dose Escalation Safety and PK Study for PLC in Healthy Chinese
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The main objective is to evaluate the effect of single dose Propionyl-L-Carnitine
Hydrochloride on clinical pharmacokinetic characteristics and its effect of clinical
pharmacokinetic characteristics and safety on healthy Chinese subjects to provide a basis for
market authorization registration.